Evidence map›Paper›PMID 38082233›Full record

ReviewBMC pulmonary medicine2023

The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases.

Fabrizio Luppi, Andreina Manfredi, Paola Faverio, Michael Brun Andersen, Francesca Bono, Fabio Pagni, Carlo Salvarani, Elisabeth Bendstrup, Marco Sebastiani

Open access · goldAbstract readReview
In one paragraph

Review in BMC pulmonary medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Fabrizio LuppiRespiratory Disease, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. fabrizio.luppi@unimib.it.
Andreina ManfrediRheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.
Paola FaverioRespiratory Disease, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Michael Brun AndersenCopenhagen University Hospital Gentofte, Copenhagen, Denmark.
Francesca BonoPathology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Fabio PagniSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Carlo SalvaraniRheumatology Unit, Dipartimento Medicina Interna e Specialità Mediche, Azienda Unità Sanitaria Locale di Reggio Emilia-Istituto di Ricerca e Cura a Carattere Scientifico, Reggio Emilia, Italy.
Elisabeth BendstrupCenter for Rare Lung Disease, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Marco SebastianiRheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.
Azienda Ospedaliera San Gerardo · ITPoliclinico di Modena · ITAarhus University Hospital · DKAzienda Sanitaria Unità Locale di Reggio Emilia · ITGentofte Hospital · DKIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Usual Interstitial Pneumonia (UIP) is characterized by progression of lung parenchyma that may be observed in various autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis and connective tissue diseases. From a diagnostic point of view, a UIP pattern related to ARDs may display imaging and pathological features able to distinguish it from that related to IPF, such as the "straight-edge" sign at HRCT and lymphoplasmacytic infiltrates at histologic specimens. Multidisciplinary approach (MDD), involving at least pulmonologist, rheumatologist and radiologist, is fundamental in the differential diagnosis process, but MDD is also required in the evaluation of severity, progression and response to treatment, that is based on the combination of changes in symptoms, pulmonary function trends, and, in selected patients, serial CT evaluation. Differently from IPF, in patients with ARDs both functional evaluation and patient-reported outcomes may be affected by systemic involvement and comorbidities, including musculoskeletal manifestations of disease. Finally, in regards to pharmacological treatment, immunosuppressants have been considered the cornerstone of therapy, despite the lack of solid evidence in most cases; recently, antifibrotic drugs were also proposed for the treatment of progressive fibrosing ILDs other than IPF. In ARD-ILD, the therapeutic choice should balance the need for the control of systemic and lung involvements with the risk of adverse events from multi-morbidities and -therapies. Purpose of this review is to summarize the definition, the radiological and morphological features of the UIP pattern in ARDs, together with risk factors, diagnostic criteria, prognostic evaluation, monitoring and management approaches of the UIP-ARDs.

Indexed as

Autoimmune DiseasesIdiopathic Pulmonary FibrosisLung Diseases, InterstitialRespiratory Distress SyndromeRheumatic DiseasesHumansLungAntifibrotic treatmentAutoimmune rheumatic diseaseDiagnosisImmunomodulatory drugInterstitial lung diseaseRheumatoid arthritisUsual interstitial pneumonia

Identifiers

PMID38082233
PMCPMC10714466
OpenAlexW4389546028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.